WHO ICTRP trial
The difference between Ester-C and ascorbic acid in adult women and men
ISRCTN49416083 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN49416083 |
|---|---|
| Public title | The difference between Ester-C and ascorbic acid in adult women and men |
| Scientific title | A cross-over comparator study between Ester-C and ascorbic acid evaluating acute pharmacokinetics in adult women and men |
| Primary sponsor | The Bountiful Company, a Nestlé Health Science Company |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United States of America |
| Conditions | Evaluate leukocyte ascorbic acid (AA) accumulation kinetics in healthy adult males and females. Not Applicable |
| Interventions | Participants will be randomized using the stratified randomization method based on age, gender and body weight. Participants will donate a fasting blood sample and then consume the assigned treatment of either 250 mg of Ester-C (providing… |
| Registration date | Mar 5, 2023 |
| Target size | 120 |
| Secondary IDs | Nil known;Nil known;Nil known |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: